Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yingchao Hu, Yapei Zhu, Wen Zhang, Jinghe Lang & Li Ning. (2019) Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer. OncoTargets and Therapy 12, pages 9715-9723.
Read now
Read now
Articles from other publishers (25)
Meirong Lu, Bianrong Gong, Yi Wang & Jingyan Li. (2022) CircBNC2 affects epithelial ovarian cancer progression through the miR-223-3p/LARP4 axis. Anti-Cancer Drugs 34:3, pages 384-394.
Crossref
Crossref
Shika Hanif Malgundkar & Yahya Tamimi. (2023) Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer. Future Science OA 9:1.
Crossref
Crossref
Wenjuan Wu, Chunhui Gao, Lipai Chen, Donghui Zhang & Suiqun Guo. (2021) Comprehensive analysis of competitive endogenous RNAs networks reveals potential prognostic biomarkers associated with epithelial ovarian cancer. Oncology Letters 22:6.
Crossref
Crossref
Razan Sheta, Magdalena Bachvarova, Marie Plante, Marie-Claude Renaud, Alexandra Sebastianelli, Jean Gregoire, Jamilet Miranda Navarro, Ricardo Bringas Perez, Jean-Yves Masson & Dimcho Bachvarov. (2020) Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy. Journal of Translational Medicine 18:1.
Crossref
Crossref
Gailing Li, Liping Han, Fang Ren, Ruitao Zhang & Guijun Qin. (2019) Prognostic value of the tumor‐specific ceRNA network in epithelial ovarian cancer. Journal of Cellular Physiology 234:12, pages 22071-22081.
Crossref
Crossref
Hubert Fleury, Laudine Communal, Euridice Carmona, Lise Portelance, Suzanna L. Arcand, Kurosh Rahimi, Patricia N. Tonin, Diane Provencher & Anne-Marie Mes-Masson. (2015) Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes & Cancer 6:9-10, pages 378-398.
Crossref
Crossref
Daniela Loessner, Boris Michael Holzapfel & Judith Ann Clements. (2014) Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses. Advanced Drug Delivery Reviews 79-80, pages 193-213.
Crossref
Crossref
Daniela Loessner, J. Paige Little, Graeme J. Pettet & Dietmar W. Hutmacher. (2013) A multiscale road map of cancer spheroids – incorporating experimental and mathematical modelling to understand cancer progression. Journal of Cell Science.
Crossref
Crossref
Diala Abd-Rabbo, Christine Abaji, Guillaume B. Cardin, Abdelali Filali-Mouhim, Caroline Arous, Lise Portelance, Enrique Escobar, Sophie Cloutier, Patricia N. Tonin, Diane M. Provencher, Anne-Marie Mes-Masson & Christine M. Maugard. (2012)
Allelic Transcripts Dosage Effect in Morphologically Normal Ovarian Cells from Heterozygous Carriers of a
BRCA1
/
2
French Canadian Founder Mutation
. Cancer Prevention Research 5:5, pages 765-777.
Crossref
Crossref
Kristin L. M. Boylan, Keith M. Skubitz & Amy P. N. Skubitz. 2010. Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy, and Prognosis
35
58
.
Cécile Le Page, Marie-Line Puiffe, Liliane Meunier, Magdalena Zietarska, Manon de Ladurantaye, Patricia N Tonin, Diane Provencher & Anne-Marie Mes-Masson. (2009) BMP-2 signaling in ovarian cancer and its association with poor prognosis. Journal of Ovarian Research 2:1.
Crossref
Crossref
Michael CJ Quinn, Daniel J Wilson, Fiona Young, Adam A Dempsey, Suzanna L Arcand, Ashley H Birch, Paulina M Wojnarowicz, Diane Provencher, Anne-Marie Mes-Masson, David Englert & Patricia N Tonin. (2009) The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles. Journal of Translational Medicine 7:1.
Crossref
Crossref
Michael C.J. Quinn, Abdelali Filali‐Mouhim, Diane M. Provencher, Anne‐Marie Mes‐Masson & Patricia N. Tonin. (2009) Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer. Molecular Carcinogenesis 48:7, pages 648-661.
Crossref
Crossref
Neal AL Cody, Magdalena Zietarska, Ali Filali-Mouhim, Diane M Provencher, Anne-Marie Mes-Masson & Patricia N Tonin. (2008) Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines. BMC Medical Genomics 1:1.
Crossref
Crossref
Magdalena Zietarska, Christine M. Maugard, Abdelali Filali‐Mouhim, Mona Alam‐Fahmy, Patricia N. Tonin, Diane M. Provencher & Anne‐Marie Mes‐Masson. (2007) Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Molecular Carcinogenesis 46:10, pages 872-885.
Crossref
Crossref
Eliana Bignotti, Renata A. Tassi, Stefano Calza, Antonella Ravaggi, Elisabetta Bandiera, Elisa Rossi, Carla Donzelli, Brunella Pasinetti, Sergio Pecorelli & Alessandro D. Santin. (2007) Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. American Journal of Obstetrics and Gynecology 196:3, pages 245.e1-245.e11.
Crossref
Crossref
Ivo Meinhold-Heerlein, Dirk Bauerschlag, Yingyao Zhou, Lisa M. Sapinoso, Keith Ching, Henry FriersonJr.Jr., Karen Bräutigam, Jalid Sehouli, Elmar Stickeler, Dominique Könsgen, Felix Hilpert, Constantin S. von Kaisenberg, Jacobus Pfisterer, Thomas Bauknecht, Walter Jonat, Norbert Arnold & Garret M. Hampton. (2007) An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma. Clinical Cancer Research 13:2, pages 458-466.
Crossref
Crossref
Amy P.N. Skubitz, Stefan E. Pambuccian, Peter A. Argenta & Keith M. Skubitz. (2006) Differential gene expression identifies subgroups of ovarian carcinoma. Translational Research 148:5, pages 223-248.
Crossref
Crossref
Cécile Le Page, Véronique Ouellet, Jason Madore, Thomas J. Hudson, Patricia N. Tonin, Diane M. Provencher & Anne‐Marie Mes‐Masson. (2005) From gene profiling to diagnostic markers: IL‐18 and FGF‐2 complement CA125 as serum‐based markers in epithelial ovarian cancer. International Journal of Cancer 118:7, pages 1750-1758.
Crossref
Crossref
C Le Page, V Ouellet, J Madore, F Ren, T J Hudson, P N Tonin, D M Provencher & A-M Mes-Masson. (2006) Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer. British Journal of Cancer 94:3, pages 436-445.
Crossref
Crossref
Véronique Ouellet, Diane M Provencher, Christine M Maugard, Cécile Le Page, Fengge Ren, Christian Lussier, Jaroslav Novak, Bing Ge, Thomas J Hudson, Patricia N Tonin & Anne-Marie Mes-Masson. (2005) Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. Oncogene 24:29, pages 4672-4687.
Crossref
Crossref
T.Z. Tan, C. Quek & G.S. Ng. (2005) Ovarian cancer diagnosis by hippocampus and neocortex-inspired learning memory structures. Neural Networks 18:5-6, pages 818-825.
Crossref
Crossref
Jean-Philippe Gagné, Pierre Gagné, Joanna M. Hunter, Marie-Ève Bonicalzi, Jean-François Lemay, Isabelle Kelly, Cécile Le Page, Diane Provencher, Anne-Marie Mes-Masson, Arnaud Droit, David Bourgais & Guy G. Poirier. (2005) Proteome profiling of human epithelial ovarian cancer cell line TOV-112D. Molecular and Cellular Biochemistry 275:1-2, pages 25-55.
Crossref
Crossref
Marcus Bernardini, Chung-Hae Lee, Ben Beheshti, Mona Prasad, Monique Albert, Paula Marrano, Heather Begley, Patricia Shaw, Al Covens, Joan Murphy, Barry Rosen, Salomon Minkin, Jeremy A. Squire & Pascale F. Macgregor. (2005) High-Resolution Mapping of Genomic Imbalance and Identification of Gene Expression Profiles Associated with Differential Chemotherapy Response in Serous Epithelial Ovarian Cancer. Neoplasia 7:6, pages 603-IN20.
Crossref
Crossref
T.Z. Tan, C. Quek & G.S. Ng. (2005) Ovarian cancer diagnosis using complementary learning fuzzy neural network. Ovarian cancer diagnosis using complementary learning fuzzy neural network.